Anne Frey Luetkemeyer MD
Assistant Professor, Medicine, UCSF School of Medicine
Join to view full profile
995 Potrero AveBox 0874San Francisco, CA 94110
Phone+1 415-476-4082
Fax+1 415-476-6953
Dr. Luetkemeyer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2003 - 2006- University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
Harvard Medical SchoolClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
- A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
- Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men Start of enrollment: 2019 Nov 26
Publications & Presentations
PubMed
- MEASURING DOXYPEP USE RELATIVE TO STI RATES AT A SAN FRANCISCO STI CLINIC REVEALS RACIAL INEQUITIES IN DISEASE PREVENTION IMPACT.Jason S Melo, Trang Q Nguyen, Oliver Bacon, Madeline Sankaran, Julia M Janssen
Sexually Transmitted Diseases. 2026-06-23 - Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.Frederick G Hayden, Masaharu Shinkai, Tristan W Clark, Anne F Luetkemeyer, Paul E Sax
The New England Journal of Medicine. 2026-05-14 - The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid seque...Fei Heng, Craig A Magaret, Nadine G Rouphael, Angela R Branche, Youyi Fong
Vaccine. 2026-03-19
Press Mentions
Antibiotic Cuts Risk of HIV, STDs After Exposure, Study SaysMay 8th, 2023- Doxy-PEP for STIs and More: Dr. Dieffenbach’s Highlights from Day 1 of CROI 2023February 21st, 2023
- Meta-Analysis Supports COVID-19 Mortality Benefit with IL-6 InhibitorsJuly 15th, 2021
Grant Support
- The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratiosUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with menUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
